Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Clinical trial NCT00321620 · COMPLETED

Trial details

NCT number: NCT00321620
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Metastases

Start date: 2006-04-01
Primary completion: 2009-10-01
Enrollment: 1904

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.